Treatment of diabetic impotence with umbilical cord blood stem cell intracavernosal transplant: Preliminary report of 7 cases

Experimental and Clinical Transplantation

Volumn 8, Issue 2, 2010, Pages

  Bahk, Jong Yoon ^a,e   Jung, Jae Hun ^a   Han, Hoon ^b   Min, Seung Ki ^c   Lee, Youn Soo ^d  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Histostem Co Ltd   (South Korea)

^c National Police Hospital   (South Korea)

^d Cho and Lee's Urology Clinic   (South Korea)

^e Medimso Co Ltd   (South Korea)

Author keywords

Cell therapy; Erectile dysfunction; Humoral factor; Transdifferentiation

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPOTENCE; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LABORATORY TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PENIS ERECTION; PENIS PROSTHESIS;

EID: 77954129006     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Gur S, Kadowitz PJ, Hellstrom WJ. A review of current progress in gene and stem cell therapy for erectile dysfunction. Expert Opin Biol Ther. 2008;8(10):1521-1538.
2. Tousoulis D, Tsarpalis K, Cokkinos D, Stefanadis C. Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications. Diabetes Obes Metab. 2008;10(10):834-842.
3. Jansson PA. Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med. 2007;262(2):173-183.
4. Goldstraw MA, Kirby MG, Bhardwa J, Kirby RS. Diabetes and the urologist: a growing problem. BJU Int. 2007;99(3):513-517.
5. Vickers MA, Wright EA. Erectile dysfunction in the patient with diabetes mellitus. Am J Manag Care. 2004;10(1 suppl):S3-S11.
6. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 1989 320(16):1025-1030.
7. Dunsmuir WP, Holmes SA. The aetiology and management of erectile, ejaculatory and fertility problems in men with diabetes mellitus. Diabet Med. 1996;13(8):700-708.
8. Wierman ME, Cassel CK. Erectile dysfunction: a multifaceted disorders. Hosp Pract (Minneap). 1998;33(10):65-74.
9. Dhindsa S, Prbhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004;89(11):5462-5468.
10. Fukui M, Soh J, Tamaka M, et al. Low serum testosterone concentration in middle-aged men with type 2 diabetes. Endocr J. 2007;54(6):871-877.
11. Bengel FM, Schachinger V, Dimmeler S. Cell-based therapies and imaging in cardiology. Eur J Nucl Med Mol Imaging. 2005;32(suppl 2):S404-S416.
12. Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005;352(20):2069-2081.
13. Reffelmann T, Koenemann S, Kloner RA. Promise of blood-and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Col Cardiol. 2009;53(4):305-308.
14. Yshimura K, Sato K, Aoi N, et al. Cell-assisted lipotransfer for facial lipoatrophy: effeicacy of clinical use of adipose derived stem cells. Dermatol Surg. 2008;34(9):1178-1185.
15. Yu G, Borlongan CV, Stahl CE, et al. Systemic delivery of umbilical cord blood cells for stroke therapy: a review. Restor Neurol Neurosci. 2009;27(1):41-54.
16. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science. 2001;293(5520):1389-1394.
17. Prochazka V, Gumulec J, Chmelova J, et al. Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot. Vnitr Lek. 2009;55(3):173-178.
18. Jiao J, Chen DF. Induction of neurogenesis in nonconventional neurogenic regions of the adult central nervous system by niche astreocyte-produced signals. Stem Cells. 2008;26(5):1221-1230.
19. Weinelt S, Peters S, Bauer P, et al. Ciliary neurotrophic factor overexpression in neural progenitor cells (ST14A) increases proliferation, metabolic activity, and resistance to stress during differentiation. J Neurosci Res. 2003;71(2):228-236.
20. Fan CG, Zhang QJ, Tang FW, Han ZB, Wang GS, Han ZC. Human umbilical cord blood cells express neurotrophic factors. Neurosci Lett. 2005;380(3):322-325.
21. Ning H, Lin G, Lue TF, Lin CS. Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation. 2006;74(9-10):510-518.
22. Ning H, Lin G, Fandel T, Banie L, Lue TF, Lin CS. Insulin growth factor signaling mediates neuron-like differentiation of adipose-tissue-derived stem cells. Differentiation. 2008;76(5):488-494.
23. Sekiguchi H, Ii M, Losordo DW. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J Cell Physiol. 2009;219(2):235-242.
24. Takeuchi H, Natsume A, Wakabayashi T, et al. Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1 and HGF-dependent manner. Neurosci Lett. 2007;426(2):69-74.
25. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360(9331):427-435.
26. Schächinger V, Erbs S, Elsässer A, et al. Investigators improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006;27(23):2775-2783.
27. Poulsom R, Alison MR, Cook T, et al. Bone marrow stem cells contribute to healing of the kidney. J Am Soc Nephrol. 2003;14 (suppl 1):S48-S54.
28. Chiu RC. Bone-marrow stem cells as a source for cell therapy. Heart Fail Rev. 2003;8(3):247-251.
29. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119(Pt 11):2204-2213.
30. Choong PF, Mok PL, Cheong SK, Leong CF, Then KY. Generating neuron-like cells from BM derived mesenchymal stromal cells in vitro. Cytotherapy. 2007;9(2):170-183.
31. Bakshi A, Hunter C, Swanger S, Lepore A, Fischer I. Minimally invasive delivery of stem cells for spinal cord injury: advantages of the lumbar puncture technique. J Neurosurg Spine. 2004;1(3):330-337.
32. Lim JH, Byeon E, Ryu HH, et al. Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. J Vet Sci. 2007;8(3):275-282.
33. Zhang QH, She MP. Biological behaviour and role of endothelial progenitor cells in vascular diseases. Chin Med J (Engl). 2007;120(24):2297-2303.
34. Kim SW, Han H, Chae GT, et al. Successful stem cell therapy using umbilical cord blood derived multipotent stem cells for Bueger's disease and ischemic limb disease animal model. Stem Cells. 2006;24(6):1620-1606.
35. Savitz SI, Rosenbaum DM, Dinsmore JH, Wechsler LR, Caplan LR. Cell transplantation for stroke. Ann Neurol. 2002;52(3):266-275.
36. Min JY, Yang Y, Sullivan MF, et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. Thorac Cardiovasc Surg. 2003;125(2):361-369.
37. Kim NN, Huang Y, Moreland RB, Kwak SS, Goldstein I, Traish A. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells. Mol Cell Biol Res Commun. 2000;4(1):10-14.
38. Maggi M, Filippi S, Ledda F, Magini A, Forti G. Erectile dysfunction: from biochemical pharmacology to advances in medical therapy. Eur J Endocrinol. 2000;143(2):143-154.
39. Rodrigues M, Granegger S, O'Grady J, Sinzinger H, Stackl W. Accumulation of platelets as a key mechanism of human erection. A scintigraphic study in patients with erectile dysfunction receiving intracavernous injection of PGE1, papaverine/phentolamine. Adv Exp Med Biol. 1997;433:79-82.
40. Bivalacqua TJ, Deng W, Kendirci M, et al. Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am J Physiol Heart Circ Physiol. 2007;292(3):H1278-H1290.
41. Pu XY, Wang XH, Gao WC, et al. Insulin-like growth factor-1 restores erectile function in aged rats: modulation the integrity of smooth muscle and nitric oxide-cyclic guanosine monophosphate signaling activity. J Sex Med. 2008;5(6):1345-1354.
42. Deng W, Bivalacqua TJ, Chattergoon NN, Hyman AL, Jeter JR Jr, Kadowitz PJ. Adenoviral gene transfer of eNOS: high-level expression in ex vivo expanded marrow stromal cells. Am J Physiol Cell Physiol. 2003;285(5):C1322-C1329.
43. Bochinski D, Lin GT, Nunes L, et al. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int. 2004;94(6):904-909
44. Song YS, Ku JH, Song ES, et al. Magnetic resonance evaluation of human mesenchymal stem cells in corpus cavernosa of rats and rabbits. Asian J Androl. 2007;9(3):361-367.
45. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A. 2003;100(14):8466-8471.
46. Koblas T, Harman SM, Saudek F. The application of umbilical cord blood cells in the treatment of diabetes mellitus. Rev Diabet Stud. 2005;2(4):228-234.
47. Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal stromal cells. Ann N Y Acad Sci. 2009;1176:101-117.
48. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy. 2003;5(6):485-489.
49. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110(10):3499-3506.
50. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30(1):42-48.
51. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99(10):3838-3843.
52. Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005;105(7):2821-2827.
53. Xu G, Zhang L, Ren G, et al. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res. 2007;17(3):240-248.
54. Le Blanc K, Pittenger M. Mesenchymal stem cells: Progress toward promise. Cytotherapy. 2005;7(1):36-45.
55. Le Blanc K, Rasmusson I, Gotherstrom C, et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohemagglutinin-activated lymphocytes. Scand J Immunol. 2004;60(3):307-315.
56. Pierdomenico L, Bonsi L, Calvitti M, et al. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation. 2005;80(6):836-842.
57. Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol. 2005;129(1):118-129
58. McIntosh K, Zvonic S, Garrett S, et al. The immunogenicity of human adipose-derived cells: Temporal changes in vitro. Stem Cells. 2006;24(5):1246-1253.
59. Wolbank S, Peterbauer A, Fahrner M, et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007;13(6):1173-1183.
60. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363(9419):1439-1441.
61. Grinnemo KH, Mansson A, Dellgren G, et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg. 2004;127(5):1293-1300.
62. Liechty KW, MacKenzie TC, Shaaban AF, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 2000;6(11):1282-1286.
63. Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow esenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005;105(7):2821-2827.
64. Barry FP, Murphy JM, English K, et al. Immunogenicity of adult mesenchymal stem cells: Lessons from the fetal allograft. Stem Cells Dev. 2005;14(3):252-265.
65. Weiss ML, Anderson C, Medicetty S, et al. Immune properties of human umbilical cord wharton's jelly-derived cells. Stem Cells. 2008;26(11):2865-2874.
66. Medicetty S, Bledsoe AR, Fahrenholtz CB, et al. Transplantation of pig stem cells into rat brain: Proliferation during the first 8 weeks. Exp Neurol. 2004;190(1):32-41.
67. Mitchell KE, Weiss ML, Mitchell BM, et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells. 2003;21(1):50-60.
68. Ji F, Wang Y, Sun H, et al. Human umbilical cord blood-derived non-hematopoietic stem cells suppress lymphocyte proliferation and CD4, CD8 expression. J Neuroimmunol. 2008;197(2):99-109
69. Siepe M, Thomsen AR, Duerkopp N, et al. Human neonatal thymus-derived mesenchymal stromal cells: characterization, differentiation, and immunomodulatory properties. Tissue Eng. Part A. 2009;15(7):1787-1796.
70. Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res. 2006;312(12):2169-2179.
71. Ye Z, Wang Y, Xie HY, Zheng SS. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells. Hepatobiliary Pancreat Dis Int. 2008;7(6):608-614.
72. Ning H, Liu G, Lin G, Yang R, Lue TF, Lin CS. Fibroblast growth factor 2 promotes endothelial differentiation of adipose tissue-derived stem cells. J Sex Med. 2009;6(4):967-979.
73. Lin G, Banie L, Ning H, Bella AJ, Lin CS, Lue TF. Potential of adipose-derived stem cells for treatment of erectile dysfunction. J Sex Med. 2009; (6 suppl 3):320-327.
74. Torella D, Ellison GM, Karakikes I, Nadal-Ginard B. Growth-factor-mediated cardiac stem cell activation in myocardial regeneration. Nat Clin Pract Cardiovasc Med. 2007;4(suppl l):S46-S51.
75. Melero-Martin JM, De Obaldia ME, Kang SY, et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res. 2008;103(2):194-202.